ALDOA and plasma cell myeloma: The results showed that ALDOA was highly expressed in bladder cancer, breast cancer, kidney cancer, liver cancer, lymphoma, myeloma, and pancreatic cancer, and low in brain and central nervous system (CNS) cancer, esophageal cancer, and leukemia.